Piper Sandler analyst Jason Bednar lowered the firm’s price target on Solventum (SOLV) to $78 from $80 and keeps an Overweight rating on the shares. The firm notes the company reported Q1 results that included a healthy revenue beat. Management passed through the top-line upside with a 50bp raise to full year organic growth guidance, while EPS guidance is unchanged as the Q1 operational beat and tailwinds from recent Fx moves are fully absorbing 35c-45c in tariff headwinds, Piper adds.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SOLV:
- Solventum Corporation Reports Q1 2025 Financial Results
- Solventum reports Q1 adjusted EPS $1.34, consensus $1.22
- Solventum sees FY25 adjusted EPS $5.45-$5.65, consensus $5.54
- Solventum price target lowered to $80 from $84 at Piper Sandler
- Solventum Corporation: Promising Growth Amidst Execution Challenges Justifies Hold Rating